Generic Avalide receives Approval

Mylan Inc. today announced that the company has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Irbesartan and Hydrochlorothiazide Tablets, 150 mg/12.5 mg and 300 mg/12.5 mg. This is the generic version of Avalide which is manufactured by